AI-Native GCC Solutions for Healthcare & Life Sciences
Generalist Engineering is a Liability in Healthcare
The greatest risk in offshore scaling isn’t cost—it’s context. When generalist developers build for high-stakes HLS, a Translation Gap occurs. Clinical nuance is lost, IP becomes fragile, and regulatory friction stalls your time-to-market.
Designial eliminates this gap. We place domain-expert practitioners at the head of every engineering vertical, ensuring your science is mastered, not just coded.
Our Solutions
Drug Discovery & Biotech Precision
Drug Discovery & Biotech Precision
We build your proprietary Agentic AI Platform for Drug Discovery within your AI-Native HLS GCC. We deploy autonomous agents for Phase I-IV biostatistics, regulatory-grade data architecture, and CSR drafting, governed by veteran biostatisticians to ensure scientific integrity.
MedTech & Medical Device Innovation
MedTech & Surgical Innovation
Your custom Agentic AI Platform for MedTech R&D. Our AI-Native HLS GCC provides engineering pods for robotic surgery and diagnostic AI. We build autonomous surgical logic and MedTech hardware workflows mentored by practicing surgeons to ensure clinical-grade precision.
Evidence-Based Revenue Ops & Growth
A bespoke Agentic AI Platform for HLS Growth. We deploy autonomous market entry and revenue ops agents that translate scientific value into top-line growth for mid-market and PE-backed companies. This is our low-friction entry point to prove scalability.
Agentic AI Platform Engineering
We architect proprietary, AI-native platforms that allow HLS firms to deploy, govern, and scale autonomous clinical and operational workflows. We build the platform with your own dedicated team so you own the IP and the intelligence layer entirely.
De-Risk Your Operational Scaling
We do not believe in long-term commitments based on slide decks. We earn trust through The Clinical Catalyst™.
This 90-day implementation phase is designed to stand up a functional Innovation Pod and achieve a specific clinical or commercial milestone. It is a low-friction, high-velocity entry point that allows you to validate our Practitioner-Governed model in real-time.
Phase I
Strategic Intake
Aligning success metrics and IP boundaries.
Phase II
Pod Deployment
Standing up your practitioner-governed engineering workforce.
Phase III
Validation
Delivery of the technical asset and Strategic Roadmap.
Your Strategic Deliverables
At the end of 90 days, you receive a validated technical or commercial asset and a full Strategic Roadmap for your permanent GCC.
From Incubation to 100% Client Ownership
Our Build-Operate-Transfer (BOT) framework ensures you maintain total control over your talent, your data, and your IP.
PHASE I: INCUBATION & ARCHITECTURE
We leverage our clinical networks to recruit domain-native talent and architect a secure, regulatory-compliant environment that mirrors your US/EU headquarters.
PHASE II: PRACTITIONER-LED OPERATIONS
Your team operates under the direct mentorship of our Global Advisory Council. We handle the operational complexity of the India-based entity while you retain full strategic control.
PHASE III: STRATEGIC HANDOVER
Once your hub reaches maturity, we execute a seamless transfer of 100% of the legal entity, talent, and IP. It isn’t a vendor relationship—it’s your people and your 2nd HQ.
Request Your High-Ownership Roadmap
Accelerate Multiples for Exit
For Private Equity-backed HLS firms, a Designial GCC is a primary value-creation lever. By establishing a high-output hub anchored in the Silicon Valley Protocol, portfolio companies reduce R&D burn by 40-60% while accelerating market output—directly enhancing EBITDA and valuation for M&A or IPO exits.
Stop Scaling in a Clinical Vacuum
Deploy your autonomous Agentic AI workforce to bridge the Translation Gap and accelerate your top line.